MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Heterozygous aprataxin gene mutation associated with atypical multiple system atrophy phenotype: a case report

A. Imarisio, A. Pilotto, A. Lupini, G. Biasiotto, I. Zanella, I. Palmieri, EM. Valente, A. Padovani (Pavia, Italy)

Meeting: 2023 International Congress

Abstract Number: 1044

Keywords: Multiple system atrophy(MSA): Clinical features, Multiple system atrophy(MSA): Genetics, Parkinsonism

Category: Genetics (Non-PD)

Objective: We describe a 73-year old patient carrying a heterozygous mutation in aprataxin (APTX) gene presenting multiple system atrophy-parkinsonian variant (MSA-P).

Background: Ataxia with oculomotor apraxia type 1 (AOA1) is a rare autosomal recessive disorder due to mutations within the APTX gene associated with prominent cerebellar involvement. Previous association studies suggested MSA-cerebellar variant as possible phenotype associated with monoallelic APTX gene mutations.

Method: Whole exome sequencing was performed in order to (i) evaluate APTX mutation status and (ii) exclude gene variants previously associated with parkinsonism.

Results: We describe the case of a patient, presenting with parkinsonism with bilateral upper limb tremor at age 71, followed in the next two years by progressive urinary incontinence, orthostatic hypotension, recurrent falls, dysarthria and dysphagia to liquids. Past medical history was unremarkable except for hypercholesterolemia and mild arterial hypertension. Brain MRI exhibited mild cerebellar and putaminal atrophy. [123I]FP-CIT SPECT showed asymmetric (right-dominant) presynaptic striatal dopaminergic degeneration and a diagnosis of MSA-P was performed. An electroneurography showed diffused sensori-motor neuropathy predominant at lower limbs. There was only poor response to L-Dopa treatment. In the next two years the patient developed progressive respiratory failure with worsening of dysphagia and died at age 75.

Neuropsychological evaluation was normal except for mild verbal memory impairment and dyscalculia. Genetic analyses revealed a nonsense monoallelic mutation of APTX (c.837G>A; p.Trp279Ter), which causes AOA1 in homozygous state.

Conclusion: APTX monoallelic mutations could be associated to MSA-P phenotypes. Further studies including functional mutation analyses are warranted to confirm our hypothesis and elucidate the related pathogenic mechanisms.

References: Baba Y, Uitti RJ, Boylan KB, et al. Aprataxin (APTX) gene mutations resembling multiple system atrophy. Parkinsonism Relat Disord. 2007;13(3):139–42.

Salvatore E, Varrone A, Criscuolo C, et al. Nigrostriatal involvement in ataxia with oculomotor apraxia type 1. J Neurol. 2008;255(1):45–8.

To cite this abstract in AMA style:

A. Imarisio, A. Pilotto, A. Lupini, G. Biasiotto, I. Zanella, I. Palmieri, EM. Valente, A. Padovani. Heterozygous aprataxin gene mutation associated with atypical multiple system atrophy phenotype: a case report [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/heterozygous-aprataxin-gene-mutation-associated-with-atypical-multiple-system-atrophy-phenotype-a-case-report/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/heterozygous-aprataxin-gene-mutation-associated-with-atypical-multiple-system-atrophy-phenotype-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley